Akzo Nobel N.V. (LON:0A00)
57.35
-0.59 (-1.01%)
At close: Oct 31, 2025
Akzo Nobel Revenue
Akzo Nobel had revenue of 2.55B EUR in the quarter ending September 30, 2025, a decrease of -4.54%. This brings the company's revenue in the last twelve months to 10.41B, down -2.03% year-over-year. In the year 2024, Akzo Nobel had annual revenue of 10.71B with 0.40% growth.
Revenue (ttm)
10.41B EUR
Revenue Growth
-2.03%
P/S Ratio
0.95
Revenue / Employee
294.53K EUR
Employees
35,327
Market Cap
8.63B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.71B | 43.00M | 0.40% |
| Dec 31, 2023 | 10.67B | -178.00M | -1.64% |
| Dec 31, 2022 | 10.85B | 1.26B | 13.13% |
| Dec 31, 2021 | 9.59B | 1.06B | 12.39% |
| Dec 31, 2020 | 8.53B | -746.00M | -8.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |